theranostics
Sign in to saveTheranostics, or theragnostics, refers to the combination of diagnosis and therapy (treatment) of disease in a single medical intervention or technique. For example, a combination of radioactive isotopes may be administered to simultaneously identify and attack cancerous lesions. Typically theranostic approaches involve a medical imaging component, such as radiotracers, contrast agents, positron emission tomography, and magnetic resonance imaging.
Clinical Trials
66 registered- PHASE2COMPLETEDA Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate CancerAustralian and New Zealand Urogenital and Prostate Cancer Trials Group · NCT03392428
- PHASE2NOT_YET_RECRUITINGPhase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown PrimaryPeter MacCallum Cancer Centre, Australia · NCT07434180
- UNKNOWNLipoprotein and Apolipoproteins With Metabolic Liver DiseasesChun-Hsiang Wang · NCT03220971
- PHASE1/PHASE2TERMINATED64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)Clarity Pharmaceuticals Ltd · NCT05633160
- PHASE1/PHASE2RECRUITINGA Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.Novartis Pharmaceuticals · NCT06247995
- NARECRUITINGTranscranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.Campus Bio-Medico University · NCT06834269
~15 min read
Article
19 sectionsContents
- Applications
- Nuclear medicine
- Theranostic pairs
- Radiological scope
- Imaging techniques
- Positron emission tomography
- Single-photon emission computed tomography
- Magnetic resonance imaging
- Therapeutic approaches
- Targeted drug delivery systems
- Gene therapy
- Radiotherapy
- Immunotherapy
- Nanomedicine
- Applications and challenges
- Oncology
- Neurology and cardiology
- Research directions
- References
Theranostics, or theragnostics, refers to the combination of diagnosis and therapy (treatment) of disease in a single medical intervention or technique. For example, a combination of radioactive isotopes may be administered to simultaneously identify and attack cancerous lesions. Typically theranostic approaches involve a medical imaging component, such as radiotracers, contrast agents, positron emission tomography, and magnetic resonance imaging.
The term "theranostic" is a portmanteau of two words, therapeutic and diagnostic. The first known use of the term is attributed to John Funkhouser, a consultant for the company Cardiovascular Diagnostic, who used it in a press release in August 1998.